High-dose oral ganciclovir for management of CMV-symptomatic infection in a child with acute lymphoblastic leukemia [3]

Medical and Pediatric Oncology

Volumn 38, Issue 4, 2002, Pages 295-296

  Castagnola, Elio ^a   Cristina, Emilio ^a   Dufour, Carlo ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; DEXAMETHASONE; GANCICLOVIR; MERCAPTOPURINE; METHOTREXATE; VINCRISTINE;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; CASE REPORT; CHILDHOOD LEUKEMIA; CYTOMEGALOVIRUS INFECTION; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LETTER; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTION;

ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; CHILD; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE;

EID: 0036207730     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1333     Document Type: Letter

References (8)

1. Cytomegalovirus
2. Asymptomatic cytomegalovirus infection in children with leukemia
3. Cytomegalovirus infection during acuthe childhood leukemia
4. Cytomegaloviremia in children with acute lymphocytic leukemia
5. Survival after primary cytomegalovirus infection with small bowel perforation and disseminated Aspergillus flavus infection in a child with acute non-lymphoblastic leukemia
6. Ganciclovir. An update of its therapeutic use in cytomegalovirus infection
7. Current concepts and challenges in the prevention and treatment of viral infections in immunocompromised cancer patients
8. Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia